{"entity":{"type":"insider","cik":"0001682017","url":"/insider/0001682017","json_url":"/insider/0001682017.json","name":"Novak Rodger","name_source":"as-filed","also_issuer":false,"cross_url":null},"coverage_statement":{"n_transactions":54,"n_filings":29,"first":"2017-04-21","last":"2021-07-01","span_basis":"filed_date"},"name_variants":[{"name":"Novak Rodger","source":"filing","n_filings":29,"first_seen":"2017-04-21","last_seen":"2021-07-01"}],"transactions":[{"id":4730770,"accession":"0001209191-21-044516","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001209191-21-044516","line_url":"/filing/0001209191-21-044516#line-1","is_derivative":false,"issuer_cik":"0001674416","issuer_name":"CRISPR Therapeutics AG","issuer_ticker":"CRSP","issuer_name_source":null,"issuer_url":"/issuer/0001674416","owner_cik":"0001682017","owner_name":"Novak Rodger","owner_display_name":"Novak Rodger","owner_url":"/insider/0001682017","role":"Director, Officer (President)","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"President","security_title":"Common Shares","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":25000.0,"shares_display":"25,000","price_per_share":165.0,"price_display":"165.00","price_state":"stated","total_value":4125000.0,"total_display":"4,125,000.00","total_whole":"4,125,000","shares_owned_after":573007.0,"shares_owned_after_display":"573,007","ownership_form":"D","is_10b5_1":null,"transaction_date":"2021-06-30","filed_date":"2021-07-01","scope":"insider"},{"id":4939821,"accession":"0001209191-21-044012","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001209191-21-044012","line_url":"/filing/0001209191-21-044012#line-1","is_derivative":false,"issuer_cik":"0001674416","issuer_name":"CRISPR Therapeutics AG","issuer_ticker":"CRSP","issuer_name_source":null,"issuer_url":"/issuer/0001674416","owner_cik":"0001682017","owner_name":"Novak Rodger","owner_display_name":"Novak Rodger","owner_url":"/insider/0001682017","role":"Director, Officer (President)","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"President","security_title":"Common Shares","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":25000.0,"shares_display":"25,000","price_per_share":156.55,"price_display":"156.55","price_state":"stated","total_value":3913750.0,"total_display":"3,913,750.00","total_whole":"3,913,750","shares_owned_after":598007.0,"shares_owned_after_display":"598,007","ownership_form":"D","is_10b5_1":null,"transaction_date":"2021-06-28","filed_date":"2021-06-30","scope":"insider"},{"id":4838051,"accession":"0001209191-21-042811","txn_seq":6,"anchor":"line-6","filing_url":"/filing/0001209191-21-042811","line_url":"/filing/0001209191-21-042811","is_derivative":false,"issuer_cik":"0001674416","issuer_name":"CRISPR Therapeutics AG","issuer_ticker":"CRSP","issuer_name_source":null,"issuer_url":"/issuer/0001674416","owner_cik":"0001682017","owner_name":"Novak Rodger","owner_display_name":"Novak Rodger","owner_url":"/insider/0001682017","role":"Director, Officer (President)","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"President","security_title":"Common Shares","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":25000.0,"shares_display":"25,000","price_per_share":128.6183292,"price_display":"128.62","price_state":"stated","total_value":3215458.23,"total_display":"3,215,458.23","total_whole":"3,215,458","shares_owned_after":630356.0,"shares_owned_after_display":"630,356","ownership_form":"D","is_10b5_1":null,"transaction_date":"2021-06-21","filed_date":"2021-06-23","scope":"insider","n_lines":6},{"id":2691526,"accession":"0001209191-20-061162","txn_seq":4,"anchor":"line-4","filing_url":"/filing/0001209191-20-061162","line_url":"/filing/0001209191-20-061162","is_derivative":false,"issuer_cik":"0001674416","issuer_name":"CRISPR Therapeutics AG","issuer_ticker":"CRSP","issuer_name_source":null,"issuer_url":"/issuer/0001674416","owner_cik":"0001682017","owner_name":"Novak Rodger","owner_display_name":"Novak Rodger","owner_url":"/insider/0001682017","role":"Director, Officer (President)","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"President","security_title":"Common Shares","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":100000.0,"shares_display":"100,000","price_per_share":125.0,"price_display":"125.00","price_state":"stated","total_value":12500000.0,"total_display":"12,500,000.00","total_whole":"12,500,000","shares_owned_after":648007.0,"shares_owned_after_display":"648,007","ownership_form":"D","is_10b5_1":null,"transaction_date":"2020-11-30","filed_date":"2020-12-02","scope":"insider","n_lines":2},{"id":3091516,"accession":"0001209191-20-054650","txn_seq":4,"anchor":"line-4","filing_url":"/filing/0001209191-20-054650","line_url":"/filing/0001209191-20-054650#line-4","is_derivative":false,"issuer_cik":"0001674416","issuer_name":"CRISPR Therapeutics AG","issuer_ticker":"CRSP","issuer_name_source":null,"issuer_url":"/issuer/0001674416","owner_cik":"0001682017","owner_name":"Novak Rodger","owner_display_name":"Novak Rodger","owner_url":"/insider/0001682017","role":"Director, Officer (President)","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"President","security_title":"Common Shares","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":2762.0,"shares_display":"2,762","price_per_share":100.0,"price_display":"100.00","price_state":"stated","total_value":276200.0,"total_display":"276,200.00","total_whole":"276,200","shares_owned_after":648007.0,"shares_owned_after_display":"648,007","ownership_form":"D","is_10b5_1":null,"transaction_date":"2020-10-09","filed_date":"2020-10-13","scope":"insider"},{"id":3091511,"accession":"0001209191-20-054650","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001209191-20-054650","line_url":"/filing/0001209191-20-054650#line-2","is_derivative":false,"issuer_cik":"0001674416","issuer_name":"CRISPR Therapeutics AG","issuer_ticker":"CRSP","issuer_name_source":null,"issuer_url":"/issuer/0001674416","owner_cik":"0001682017","owner_name":"Novak Rodger","owner_display_name":"Novak Rodger","owner_url":"/insider/0001682017","role":"Director, Officer (President)","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"President","security_title":"Common Shares","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":22238.0,"shares_display":"22,238","price_per_share":100.0,"price_display":"100.00","price_state":"stated","total_value":2223800.0,"total_display":"2,223,800.00","total_whole":"2,223,800","shares_owned_after":648007.0,"shares_owned_after_display":"648,007","ownership_form":"D","is_10b5_1":null,"transaction_date":"2020-10-08","filed_date":"2020-10-13","scope":"insider"},{"id":2882440,"accession":"0001209191-20-049425","txn_seq":5,"anchor":"line-5","filing_url":"/filing/0001209191-20-049425","line_url":"/filing/0001209191-20-049425","is_derivative":false,"issuer_cik":"0001674416","issuer_name":"CRISPR Therapeutics AG","issuer_ticker":"CRSP","issuer_name_source":null,"issuer_url":"/issuer/0001674416","owner_cik":"0001682017","owner_name":"Novak Rodger","owner_display_name":"Novak Rodger","owner_url":"/insider/0001682017","role":"Director, Officer (President)","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"President","security_title":"Common Shares","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":25000.0,"shares_display":"25,000","price_per_share":92.623108,"price_display":"92.62","price_state":"stated","total_value":2315577.7,"total_display":"2,315,577.70","total_whole":"2,315,578","shares_owned_after":651847.0,"shares_owned_after_display":"651,847","ownership_form":"D","is_10b5_1":null,"transaction_date":"2020-09-01","filed_date":"2020-09-03","scope":"insider","n_lines":3},{"id":2882255,"accession":"0001209191-20-047908","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001209191-20-047908","line_url":"/filing/0001209191-20-047908#line-2","is_derivative":false,"issuer_cik":"0001674416","issuer_name":"CRISPR Therapeutics AG","issuer_ticker":"CRSP","issuer_name_source":null,"issuer_url":"/issuer/0001674416","owner_cik":"0001682017","owner_name":"Novak Rodger","owner_display_name":"Novak Rodger","owner_url":"/insider/0001682017","role":"Director, Officer (President)","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"President","security_title":"Common Shares","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":25000.0,"shares_display":"25,000","price_per_share":100.0,"price_display":"100.00","price_state":"stated","total_value":2500000.0,"total_display":"2,500,000.00","total_whole":"2,500,000","shares_owned_after":648007.0,"shares_owned_after_display":"648,007","ownership_form":"D","is_10b5_1":null,"transaction_date":"2020-08-19","filed_date":"2020-08-21","scope":"insider"},{"id":2207872,"accession":"0000899243-20-018812","txn_seq":3,"anchor":"line-3","filing_url":"/filing/0000899243-20-018812","line_url":"/filing/0000899243-20-018812#line-3","is_derivative":false,"issuer_cik":"0001674416","issuer_name":"CRISPR Therapeutics AG","issuer_ticker":"CRSP","issuer_name_source":null,"issuer_url":"/issuer/0001674416","owner_cik":"0001682017","owner_name":"Novak Rodger","owner_display_name":"Novak Rodger","owner_url":"/insider/0001682017","role":"Director, Officer (President)","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"President","security_title":"Common Shares","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":25000.0,"shares_display":"25,000","price_per_share":90.0,"price_display":"90.00","price_state":"stated","total_value":2250000.0,"total_display":"2,250,000.00","total_whole":"2,250,000","shares_owned_after":648007.0,"shares_owned_after_display":"648,007","ownership_form":"D","is_10b5_1":null,"transaction_date":"2020-07-07","filed_date":"2020-07-09","scope":"insider"},{"id":2331763,"accession":"0000950123-20-006683","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0000950123-20-006683","line_url":"/filing/0000950123-20-006683#line-1","is_derivative":false,"issuer_cik":"0001674416","issuer_name":"CRISPR Therapeutics AG","issuer_ticker":"CRSP","issuer_name_source":null,"issuer_url":"/issuer/0001674416","owner_cik":"0001682017","owner_name":"Novak Rodger","owner_display_name":"Novak Rodger","owner_url":"/insider/0001682017","role":"Director, Officer (President)","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"President","security_title":"Common Shares","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":50000.0,"shares_display":"50,000","price_per_share":80.0,"price_display":"80.00","price_state":"stated","total_value":4000000.0,"total_display":"4,000,000.00","total_whole":"4,000,000","shares_owned_after":648007.0,"shares_owned_after_display":"648,007","ownership_form":"D","is_10b5_1":null,"transaction_date":"2020-07-01","filed_date":"2020-07-06","scope":"insider"},{"id":2180574,"accession":"0001209191-20-038910","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001209191-20-038910","line_url":"/filing/0001209191-20-038910#line-1","is_derivative":false,"issuer_cik":"0001674416","issuer_name":"CRISPR Therapeutics AG","issuer_ticker":"CRSP","issuer_name_source":null,"issuer_url":"/issuer/0001674416","owner_cik":"0001682017","owner_name":"Novak Rodger","owner_display_name":"Novak Rodger","owner_url":"/insider/0001682017","role":"Director, Officer (President)","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"President","security_title":"Common Shares","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":50000.0,"shares_display":"50,000","price_per_share":75.0,"price_display":"75.00","price_state":"stated","total_value":3750000.0,"total_display":"3,750,000.00","total_whole":"3,750,000","shares_owned_after":698007.0,"shares_owned_after_display":"698,007","ownership_form":"D","is_10b5_1":null,"transaction_date":"2020-06-23","filed_date":"2020-06-25","scope":"insider"},{"id":2180002,"accession":"0001209191-20-032317","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001209191-20-032317","line_url":"/filing/0001209191-20-032317#line-2","is_derivative":false,"issuer_cik":"0001674416","issuer_name":"CRISPR Therapeutics AG","issuer_ticker":"CRSP","issuer_name_source":null,"issuer_url":"/issuer/0001674416","owner_cik":"0001682017","owner_name":"Novak Rodger","owner_display_name":"Novak Rodger","owner_url":"/insider/0001682017","role":"Director, Officer (President)","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"President","security_title":"Common Shares","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":36616.0,"shares_display":"36,616","price_per_share":70.27,"price_display":"70.27","price_state":"stated","total_value":2573006.32,"total_display":"2,573,006.32","total_whole":"2,573,006","shares_owned_after":748007.0,"shares_owned_after_display":"748,007","ownership_form":"D","is_10b5_1":null,"transaction_date":"2020-05-26","filed_date":"2020-05-27","scope":"insider"},{"id":2179997,"accession":"0001209191-20-032317","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001209191-20-032317","line_url":"/filing/0001209191-20-032317#line-1","is_derivative":false,"issuer_cik":"0001674416","issuer_name":"CRISPR Therapeutics AG","issuer_ticker":"CRSP","issuer_name_source":null,"issuer_url":"/issuer/0001674416","owner_cik":"0001682017","owner_name":"Novak Rodger","owner_display_name":"Novak Rodger","owner_url":"/insider/0001682017","role":"Director, Officer (President)","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"President","security_title":"Common Shares","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":13384.0,"shares_display":"13,384","price_per_share":70.01,"price_display":"70.01","price_state":"stated","total_value":937013.84,"total_display":"937,013.84","total_whole":"937,014","shares_owned_after":784623.0,"shares_owned_after_display":"784,623","ownership_form":"D","is_10b5_1":null,"transaction_date":"2020-05-22","filed_date":"2020-05-27","scope":"insider"},{"id":3166386,"accession":"0001209191-20-031299","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001209191-20-031299","line_url":"/filing/0001209191-20-031299#line-1","is_derivative":false,"issuer_cik":"0001674416","issuer_name":"CRISPR Therapeutics AG","issuer_ticker":"CRSP","issuer_name_source":null,"issuer_url":"/issuer/0001674416","owner_cik":"0001682017","owner_name":"Novak Rodger","owner_display_name":"Novak Rodger","owner_url":"/insider/0001682017","role":"Director, Officer (President)","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"President","security_title":"Common Shares","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":50000.0,"shares_display":"50,000","price_per_share":65.0,"price_display":"65.00","price_state":"stated","total_value":3250000.0,"total_display":"3,250,000.00","total_whole":"3,250,000","shares_owned_after":798007.0,"shares_owned_after_display":"798,007","ownership_form":"D","is_10b5_1":null,"transaction_date":"2020-05-19","filed_date":"2020-05-21","scope":"insider"},{"id":7951812,"accession":"0001209191-19-057604","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001209191-19-057604","line_url":"/filing/0001209191-19-057604#line-2","is_derivative":false,"issuer_cik":"0001674416","issuer_name":"CRISPR Therapeutics AG","issuer_ticker":"CRSP","issuer_name_source":null,"issuer_url":"/issuer/0001674416","owner_cik":"0001682017","owner_name":"Novak Rodger","owner_display_name":"Novak Rodger","owner_url":"/insider/0001682017","role":"Director, Officer (President)","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"President","security_title":"Common Shares","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":33618.0,"shares_display":"33,618","price_per_share":70.0,"price_display":"70.00","price_state":"stated","total_value":2353260.0,"total_display":"2,353,260.00","total_whole":"2,353,260","shares_owned_after":0.0,"shares_owned_after_display":"0","ownership_form":"D","is_10b5_1":null,"transaction_date":"2019-11-19","filed_date":"2019-11-21","scope":"insider"},{"id":8722954,"accession":"0000899243-19-019531","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0000899243-19-019531","line_url":"/filing/0000899243-19-019531#line-1","is_derivative":false,"issuer_cik":"0001674416","issuer_name":"CRISPR Therapeutics AG","issuer_ticker":"CRSP","issuer_name_source":null,"issuer_url":"/issuer/0001674416","owner_cik":"0001682017","owner_name":"Novak Rodger","owner_display_name":"Novak Rodger","owner_url":"/insider/0001682017","role":"Director, Officer (President)","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"President","security_title":"Common Shares","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":50000.0,"shares_display":"50,000","price_per_share":50.0013,"price_display":"50.00","price_state":"stated","total_value":2500065.0,"total_display":"2,500,065.00","total_whole":"2,500,065","shares_owned_after":848007.0,"shares_owned_after_display":"848,007","ownership_form":"D","is_10b5_1":null,"transaction_date":"2019-07-10","filed_date":"2019-07-12","scope":"insider"},{"id":8634093,"accession":"0000899243-19-016636","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0000899243-19-016636","line_url":"/filing/0000899243-19-016636#line-1","is_derivative":false,"issuer_cik":"0001674416","issuer_name":"CRISPR Therapeutics AG","issuer_ticker":"CRSP","issuer_name_source":null,"issuer_url":"/issuer/0001674416","owner_cik":"0001682017","owner_name":"Novak Rodger","owner_display_name":"Novak Rodger","owner_url":"/insider/0001682017","role":"Director, Officer (President)","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"President","security_title":"Common Shares","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":50000.0,"shares_display":"50,000","price_per_share":45.0,"price_display":"45.00","price_state":"stated","total_value":2250000.0,"total_display":"2,250,000.00","total_whole":"2,250,000","shares_owned_after":898007.0,"shares_owned_after_display":"898,007","ownership_form":"D","is_10b5_1":null,"transaction_date":"2019-06-10","filed_date":"2019-06-12","scope":"insider"},{"id":7830484,"accession":"0000899243-19-006186","txn_seq":4,"anchor":"line-4","filing_url":"/filing/0000899243-19-006186","line_url":"/filing/0000899243-19-006186","is_derivative":false,"issuer_cik":"0001674416","issuer_name":"CRISPR Therapeutics AG","issuer_ticker":"CRSP","issuer_name_source":null,"issuer_url":"/issuer/0001674416","owner_cik":"0001682017","owner_name":"Novak Rodger","owner_display_name":"Novak Rodger","owner_url":"/insider/0001682017","role":"Director, Officer (President)","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"President","security_title":"Common Shares","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":76527.0,"shares_display":"76,527","price_per_share":40.44638113737635,"price_display":"40.45","price_state":"stated","total_value":3095240.2093,"total_display":"3,095,240.21","total_whole":"3,095,240","shares_owned_after":960419.0,"shares_owned_after_display":"960,419","ownership_form":"D","is_10b5_1":null,"transaction_date":"2019-03-04","filed_date":"2019-03-05","scope":"insider","n_lines":3},{"id":7830474,"accession":"0000899243-19-006186","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0000899243-19-006186","line_url":"/filing/0000899243-19-006186#line-1","is_derivative":false,"issuer_cik":"0001674416","issuer_name":"CRISPR Therapeutics AG","issuer_ticker":"CRSP","issuer_name_source":null,"issuer_url":"/issuer/0001674416","owner_cik":"0001682017","owner_name":"Novak Rodger","owner_display_name":"Novak Rodger","owner_url":"/insider/0001682017","role":"Director, Officer (President)","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"President","security_title":"Common Shares","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":8693.0,"shares_display":"8,693","price_per_share":40.0088,"price_display":"40.01","price_state":"stated","total_value":347796.4984,"total_display":"347,796.50","total_whole":"347,796","shares_owned_after":1024534.0,"shares_owned_after_display":"1,024,534","ownership_form":"D","is_10b5_1":null,"transaction_date":"2019-03-01","filed_date":"2019-03-05","scope":"insider"},{"id":8143418,"accession":"0000899243-19-005001","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0000899243-19-005001","line_url":"/filing/0000899243-19-005001#line-1","is_derivative":false,"issuer_cik":"0001674416","issuer_name":"CRISPR Therapeutics AG","issuer_ticker":"CRSP","issuer_name_source":null,"issuer_url":"/issuer/0001674416","owner_cik":"0001682017","owner_name":"Novak Rodger","owner_display_name":"Novak Rodger","owner_url":"/insider/0001682017","role":"Director, Officer (President)","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"President","security_title":"Common Shares","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":14780.0,"shares_display":"14,780","price_per_share":40.0022,"price_display":"40.00","price_state":"stated","total_value":591232.516,"total_display":"591,232.52","total_whole":"591,233","shares_owned_after":1033227.0,"shares_owned_after_display":"1,033,227","ownership_form":"D","is_10b5_1":null,"transaction_date":"2019-02-25","filed_date":"2019-02-27","scope":"insider"},{"id":8663671,"accession":"0000899243-19-000956","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0000899243-19-000956","line_url":"/filing/0000899243-19-000956#line-2","is_derivative":false,"issuer_cik":"0001674416","issuer_name":"CRISPR Therapeutics AG","issuer_ticker":"CRSP","issuer_name_source":null,"issuer_url":"/issuer/0001674416","owner_cik":"0001682017","owner_name":"Novak Rodger","owner_display_name":"Novak Rodger","owner_url":"/insider/0001682017","role":"Director, Officer (President)","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"President","security_title":"Common Shares","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":82690.0,"shares_display":"82,690","price_per_share":35.01,"price_display":"35.01","price_state":"stated","total_value":2894976.9,"total_display":"2,894,976.90","total_whole":"2,894,977","shares_owned_after":1048007.0,"shares_owned_after_display":"1,048,007","ownership_form":"D","is_10b5_1":null,"transaction_date":"2019-01-09","filed_date":"2019-01-10","scope":"insider"},{"id":8663668,"accession":"0000899243-19-000956","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0000899243-19-000956","line_url":"/filing/0000899243-19-000956#line-1","is_derivative":false,"issuer_cik":"0001674416","issuer_name":"CRISPR Therapeutics AG","issuer_ticker":"CRSP","issuer_name_source":null,"issuer_url":"/issuer/0001674416","owner_cik":"0001682017","owner_name":"Novak Rodger","owner_display_name":"Novak Rodger","owner_url":"/insider/0001682017","role":"Director, Officer (President)","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"President","security_title":"Common Shares","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":17310.0,"shares_display":"17,310","price_per_share":35.09,"price_display":"35.09","price_state":"stated","total_value":607407.9,"total_display":"607,407.90","total_whole":"607,408","shares_owned_after":1130697.0,"shares_owned_after_display":"1,130,697","ownership_form":"D","is_10b5_1":null,"transaction_date":"2019-01-08","filed_date":"2019-01-10","scope":"insider"},{"id":6744531,"accession":"0000899243-18-013577","txn_seq":3,"anchor":"line-3","filing_url":"/filing/0000899243-18-013577","line_url":"/filing/0000899243-18-013577#line-3","is_derivative":false,"issuer_cik":"0001674416","issuer_name":"CRISPR Therapeutics AG","issuer_ticker":"CRSP","issuer_name_source":null,"issuer_url":"/issuer/0001674416","owner_cik":"0001682017","owner_name":"Novak Rodger","owner_display_name":"Novak Rodger","owner_url":"/insider/0001682017","role":"Director, Officer (President)","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"President","security_title":"Common Shares","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":75000.0,"shares_display":"75,000","price_per_share":60.0,"price_display":"60.00","price_state":"stated","total_value":4500000.0,"total_display":"4,500,000.00","total_whole":"4,500,000","shares_owned_after":1148007.0,"shares_owned_after_display":"1,148,007","ownership_form":"D","is_10b5_1":null,"transaction_date":"2018-05-17","filed_date":"2018-05-21","scope":"insider"},{"id":4691552,"accession":"0000899243-17-021477","txn_seq":3,"anchor":"line-3","filing_url":"/filing/0000899243-17-021477","line_url":"/filing/0000899243-17-021477#line-3","is_derivative":false,"issuer_cik":"0001674416","issuer_name":"CRISPR Therapeutics AG","issuer_ticker":"CRSP","issuer_name_source":null,"issuer_url":"/issuer/0001674416","owner_cik":"0001682017","owner_name":"Novak Rodger","owner_display_name":"Novak Rodger","owner_url":"/insider/0001682017","role":"Director, Officer (Chief Executive Officer)","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Executive Officer","security_title":"Common Shares","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":3853.0,"shares_display":"3,853","price_per_share":20.3271,"price_display":"20.33","price_state":"stated","total_value":78320.3163,"total_display":"78,320.32","total_whole":"78,320","shares_owned_after":1148007.0,"shares_owned_after_display":"1,148,007","ownership_form":"D","is_10b5_1":null,"transaction_date":"2017-09-05","filed_date":"2017-09-05","scope":"insider"},{"id":4691541,"accession":"0000899243-17-021477","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0000899243-17-021477","line_url":"/filing/0000899243-17-021477#line-1","is_derivative":false,"issuer_cik":"0001674416","issuer_name":"CRISPR Therapeutics AG","issuer_ticker":"CRSP","issuer_name_source":null,"issuer_url":"/issuer/0001674416","owner_cik":"0001682017","owner_name":"Novak Rodger","owner_display_name":"Novak Rodger","owner_url":"/insider/0001682017","role":"Director, Officer (Chief Executive Officer)","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Executive Officer","security_title":"Common Shares","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":14617.0,"shares_display":"14,617","price_per_share":20.8711,"price_display":"20.87","price_state":"stated","total_value":305072.8687,"total_display":"305,072.87","total_whole":"305,073","shares_owned_after":1148007.0,"shares_owned_after_display":"1,148,007","ownership_form":"D","is_10b5_1":null,"transaction_date":"2017-08-31","filed_date":"2017-09-05","scope":"insider"},{"id":4809084,"accession":"0000899243-17-021281","txn_seq":4,"anchor":"line-4","filing_url":"/filing/0000899243-17-021281","line_url":"/filing/0000899243-17-021281#line-4","is_derivative":false,"issuer_cik":"0001674416","issuer_name":"CRISPR Therapeutics AG","issuer_ticker":"CRSP","issuer_name_source":null,"issuer_url":"/issuer/0001674416","owner_cik":"0001682017","owner_name":"Novak Rodger","owner_display_name":"Novak Rodger","owner_url":"/insider/0001682017","role":"Director, Officer (Chief Executive Officer)","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Executive Officer","security_title":"Common Shares","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":58103.0,"shares_display":"58,103","price_per_share":20.3079,"price_display":"20.31","price_state":"stated","total_value":1179949.9137,"total_display":"1,179,949.91","total_whole":"1,179,950","shares_owned_after":1162624.0,"shares_owned_after_display":"1,162,624","ownership_form":"D","is_10b5_1":null,"transaction_date":"2017-08-30","filed_date":"2017-08-30","scope":"insider"},{"id":4809074,"accession":"0000899243-17-021281","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0000899243-17-021281","line_url":"/filing/0000899243-17-021281#line-2","is_derivative":false,"issuer_cik":"0001674416","issuer_name":"CRISPR Therapeutics AG","issuer_ticker":"CRSP","issuer_name_source":null,"issuer_url":"/issuer/0001674416","owner_cik":"0001682017","owner_name":"Novak Rodger","owner_display_name":"Novak Rodger","owner_url":"/insider/0001682017","role":"Director, Officer (Chief Executive Officer)","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Executive Officer","security_title":"Common Shares","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":17692.0,"shares_display":"17,692","price_per_share":20.061,"price_display":"20.06","price_state":"stated","total_value":354919.212,"total_display":"354,919.21","total_whole":"354,919","shares_owned_after":1215005.0,"shares_owned_after_display":"1,215,005","ownership_form":"D","is_10b5_1":null,"transaction_date":"2017-08-28","filed_date":"2017-08-30","scope":"insider"},{"id":4808878,"accession":"0000899243-17-017094","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0000899243-17-017094","line_url":"/filing/0000899243-17-017094#line-2","is_derivative":false,"issuer_cik":"0001674416","issuer_name":"CRISPR Therapeutics AG","issuer_ticker":"CRSP","issuer_name_source":null,"issuer_url":"/issuer/0001674416","owner_cik":"0001682017","owner_name":"Novak Rodger","owner_display_name":"Novak Rodger","owner_url":"/insider/0001682017","role":"Director, Officer (Chief Executive Officer)","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Executive Officer","security_title":"Common Shares","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":10825.0,"shares_display":"10,825","price_per_share":15.3707,"price_display":"15.37","price_state":"stated","total_value":166387.8275,"total_display":"166,387.83","total_whole":"166,388","shares_owned_after":1215005.0,"shares_owned_after_display":"1,215,005","ownership_form":"D","is_10b5_1":null,"transaction_date":"2017-06-22","filed_date":"2017-06-23","scope":"insider"},{"id":4391268,"accession":"0000899243-17-016873","txn_seq":6,"anchor":"line-6","filing_url":"/filing/0000899243-17-016873","line_url":"/filing/0000899243-17-016873#line-6","is_derivative":false,"issuer_cik":"0001674416","issuer_name":"CRISPR Therapeutics AG","issuer_ticker":"CRSP","issuer_name_source":null,"issuer_url":"/issuer/0001674416","owner_cik":"0001682017","owner_name":"Novak Rodger","owner_display_name":"Novak Rodger","owner_url":"/insider/0001682017","role":"Director, Officer (Chief Executive Officer)","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Executive Officer","security_title":"Common Shares","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":11578.0,"shares_display":"11,578","price_per_share":15.0152,"price_display":"15.02","price_state":"stated","total_value":173845.9856,"total_display":"173,845.99","total_whole":"173,846","shares_owned_after":1215005.0,"shares_owned_after_display":"1,215,005","ownership_form":"D","is_10b5_1":null,"transaction_date":"2017-06-21","filed_date":"2017-06-21","scope":"insider"},{"id":4391259,"accession":"0000899243-17-016873","txn_seq":4,"anchor":"line-4","filing_url":"/filing/0000899243-17-016873","line_url":"/filing/0000899243-17-016873#line-4","is_derivative":false,"issuer_cik":"0001674416","issuer_name":"CRISPR Therapeutics AG","issuer_ticker":"CRSP","issuer_name_source":null,"issuer_url":"/issuer/0001674416","owner_cik":"0001682017","owner_name":"Novak Rodger","owner_display_name":"Novak Rodger","owner_url":"/insider/0001682017","role":"Director, Officer (Chief Executive Officer)","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Executive Officer","security_title":"Common Shares","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":3252.0,"shares_display":"3,252","price_per_share":15.0015,"price_display":"15.00","price_state":"stated","total_value":48784.878,"total_display":"48,784.88","total_whole":"48,785","shares_owned_after":1215005.0,"shares_owned_after_display":"1,215,005","ownership_form":"D","is_10b5_1":null,"transaction_date":"2017-06-20","filed_date":"2017-06-21","scope":"insider"},{"id":4391252,"accession":"0000899243-17-016873","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0000899243-17-016873","line_url":"/filing/0000899243-17-016873#line-2","is_derivative":false,"issuer_cik":"0001674416","issuer_name":"CRISPR Therapeutics AG","issuer_ticker":"CRSP","issuer_name_source":null,"issuer_url":"/issuer/0001674416","owner_cik":"0001682017","owner_name":"Novak Rodger","owner_display_name":"Novak Rodger","owner_url":"/insider/0001682017","role":"Director, Officer (Chief Executive Officer)","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Executive Officer","security_title":"Common Shares","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":15392.0,"shares_display":"15,392","price_per_share":15.0,"price_display":"15.00","price_state":"stated","total_value":230880.0,"total_display":"230,880.00","total_whole":"230,880","shares_owned_after":1215005.0,"shares_owned_after_display":"1,215,005","ownership_form":"D","is_10b5_1":null,"transaction_date":"2017-06-19","filed_date":"2017-06-21","scope":"insider"},{"id":5113606,"accession":"0000899243-17-016100","txn_seq":4,"anchor":"line-4","filing_url":"/filing/0000899243-17-016100","line_url":"/filing/0000899243-17-016100#line-4","is_derivative":false,"issuer_cik":"0001674416","issuer_name":"CRISPR Therapeutics AG","issuer_ticker":"CRSP","issuer_name_source":null,"issuer_url":"/issuer/0001674416","owner_cik":"0001682017","owner_name":"Novak Rodger","owner_display_name":"Novak Rodger","owner_url":"/insider/0001682017","role":"Director, Officer (Chief Executive Officer)","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Executive Officer","security_title":"Common Shares","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":1100.0,"shares_display":"1,100","price_per_share":15.0755,"price_display":"15.08","price_state":"stated","total_value":16583.05,"total_display":"16,583.05","total_whole":"16,583","shares_owned_after":1215005.0,"shares_owned_after_display":"1,215,005","ownership_form":"D","is_10b5_1":null,"transaction_date":"2017-06-09","filed_date":"2017-06-12","scope":"insider"},{"id":5113585,"accession":"0000899243-17-016100","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0000899243-17-016100","line_url":"/filing/0000899243-17-016100#line-2","is_derivative":false,"issuer_cik":"0001674416","issuer_name":"CRISPR Therapeutics AG","issuer_ticker":"CRSP","issuer_name_source":null,"issuer_url":"/issuer/0001674416","owner_cik":"0001682017","owner_name":"Novak Rodger","owner_display_name":"Novak Rodger","owner_url":"/insider/0001682017","role":"Director, Officer (Chief Executive Officer)","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Executive Officer","security_title":"Common Shares","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":4203.0,"shares_display":"4,203","price_per_share":15.0,"price_display":"15.00","price_state":"stated","total_value":63045.0,"total_display":"63,045.00","total_whole":"63,045","shares_owned_after":1215005.0,"shares_owned_after_display":"1,215,005","ownership_form":"D","is_10b5_1":null,"transaction_date":"2017-06-08","filed_date":"2017-06-12","scope":"insider"},{"id":4566696,"accession":"0000899243-17-015008","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0000899243-17-015008","line_url":"/filing/0000899243-17-015008#line-2","is_derivative":false,"issuer_cik":"0001674416","issuer_name":"CRISPR Therapeutics AG","issuer_ticker":"CRSP","issuer_name_source":null,"issuer_url":"/issuer/0001674416","owner_cik":"0001682017","owner_name":"Novak Rodger","owner_display_name":"Novak Rodger","owner_url":"/insider/0001682017","role":"Director, Officer (Chief Executive Officer)","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Executive Officer","security_title":"Common Shares","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":3650.0,"shares_display":"3,650","price_per_share":15.0216,"price_display":"15.02","price_state":"stated","total_value":54828.84,"total_display":"54,828.84","total_whole":"54,829","shares_owned_after":1215005.0,"shares_owned_after_display":"1,215,005","ownership_form":"D","is_10b5_1":null,"transaction_date":"2017-05-30","filed_date":"2017-06-01","scope":"insider"},{"id":5113362,"accession":"0000899243-17-013806","txn_seq":4,"anchor":"line-4","filing_url":"/filing/0000899243-17-013806","line_url":"/filing/0000899243-17-013806#line-4","is_derivative":false,"issuer_cik":"0001674416","issuer_name":"CRISPR Therapeutics AG","issuer_ticker":"CRSP","issuer_name_source":null,"issuer_url":"/issuer/0001674416","owner_cik":"0001682017","owner_name":"Novak Rodger","owner_display_name":"Novak Rodger","owner_url":"/insider/0001682017","role":"Director, Officer (Chief Executive Officer)","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Executive Officer","security_title":"Common Shares","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":25923.0,"shares_display":"25,923","price_per_share":16.0312,"price_display":"16.03","price_state":"stated","total_value":415576.7976,"total_display":"415,576.80","total_whole":"415,577","shares_owned_after":1215005.0,"shares_owned_after_display":"1,215,005","ownership_form":"D","is_10b5_1":null,"transaction_date":"2017-05-17","filed_date":"2017-05-18","scope":"insider"},{"id":5113342,"accession":"0000899243-17-013806","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0000899243-17-013806","line_url":"/filing/0000899243-17-013806#line-2","is_derivative":false,"issuer_cik":"0001674416","issuer_name":"CRISPR Therapeutics AG","issuer_ticker":"CRSP","issuer_name_source":null,"issuer_url":"/issuer/0001674416","owner_cik":"0001682017","owner_name":"Novak Rodger","owner_display_name":"Novak Rodger","owner_url":"/insider/0001682017","role":"Director, Officer (Chief Executive Officer)","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Executive Officer","security_title":"Common Shares","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":24077.0,"shares_display":"24,077","price_per_share":16.5005,"price_display":"16.50","price_state":"stated","total_value":397282.5385,"total_display":"397,282.54","total_whole":"397,283","shares_owned_after":1215005.0,"shares_owned_after_display":"1,215,005","ownership_form":"D","is_10b5_1":null,"transaction_date":"2017-05-16","filed_date":"2017-05-18","scope":"insider"},{"id":4768063,"accession":"0000899243-17-012492","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0000899243-17-012492","line_url":"/filing/0000899243-17-012492#line-2","is_derivative":false,"issuer_cik":"0001674416","issuer_name":"CRISPR Therapeutics AG","issuer_ticker":"CRSP","issuer_name_source":null,"issuer_url":"/issuer/0001674416","owner_cik":"0001682017","owner_name":"Novak Rodger","owner_display_name":"Novak Rodger","owner_url":"/insider/0001682017","role":"Director, Officer (Chief Executive Officer)","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Executive Officer","security_title":"Common Shares","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":616.0,"shares_display":"616","price_per_share":16.9248,"price_display":"16.92","price_state":"stated","total_value":10425.6768,"total_display":"10,425.68","total_whole":"10,426","shares_owned_after":1215005.0,"shares_owned_after_display":"1,215,005","ownership_form":"D","is_10b5_1":null,"transaction_date":"2017-05-05","filed_date":"2017-05-09","scope":"insider"},{"id":5273939,"accession":"0000899243-17-011883","txn_seq":7,"anchor":"line-7","filing_url":"/filing/0000899243-17-011883","line_url":"/filing/0000899243-17-011883#line-7","is_derivative":false,"issuer_cik":"0001674416","issuer_name":"CRISPR Therapeutics AG","issuer_ticker":"CRSP","issuer_name_source":null,"issuer_url":"/issuer/0001674416","owner_cik":"0001682017","owner_name":"Novak Rodger","owner_display_name":"Novak Rodger","owner_url":"/insider/0001682017","role":"Director, Officer (Chief Executive Officer)","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Executive Officer","security_title":"Common Shares","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":13191.0,"shares_display":"13,191","price_per_share":16.3718,"price_display":"16.37","price_state":"stated","total_value":215960.4138,"total_display":"215,960.41","total_whole":"215,960","shares_owned_after":1215005.0,"shares_owned_after_display":"1,215,005","ownership_form":"D","is_10b5_1":null,"transaction_date":"2017-05-04","filed_date":"2017-05-04","scope":"insider"},{"id":5273934,"accession":"0000899243-17-011883","txn_seq":5,"anchor":"line-5","filing_url":"/filing/0000899243-17-011883","line_url":"/filing/0000899243-17-011883","is_derivative":false,"issuer_cik":"0001674416","issuer_name":"CRISPR Therapeutics AG","issuer_ticker":"CRSP","issuer_name_source":null,"issuer_url":"/issuer/0001674416","owner_cik":"0001682017","owner_name":"Novak Rodger","owner_display_name":"Novak Rodger","owner_url":"/insider/0001682017","role":"Director, Officer (Chief Executive Officer)","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Executive Officer","security_title":"Common Shares","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":20269.0,"shares_display":"20,269","price_per_share":16.08299592481129,"price_display":"16.08","price_state":"stated","total_value":325986.2444,"total_display":"325,986.24","total_whole":"325,986","shares_owned_after":1216027.0,"shares_owned_after_display":"1,216,027","ownership_form":"D","is_10b5_1":null,"transaction_date":"2017-05-03","filed_date":"2017-05-04","scope":"insider","n_lines":2}],"collapsed":true,"next_cursor":"2017-05-03|5273931","ledger_fault":false,"count":{"value":54,"kind":"exact"},"open_market_only":false,"composition":{"kind":"exact","rows":[{"code":"P","label":"Open-market purchase","n":0,"open_market":true},{"code":"S","label":"Open-market sale","n":54,"open_market":true},{"code":"M","label":"Option exercise","n":0,"open_market":false},{"code":"A","label":"Grant or award","n":0,"open_market":false},{"code":"F","label":"Tax withholding","n":0,"open_market":false},{"code":"D","label":"Disposition to the issuer","n":0,"open_market":false},{"code":"X","label":"In-the-money option exercise","n":0,"open_market":false}],"total":54},"affiliations":[{"type":"issuer","type_label":"ISSUER","cik":"0001674416","name":"CRISPR Therapeutics AG","url":"/issuer/0001674416","role":"Director, Officer (President)","n_filings":29,"first_seen":"2017-04-21","last_seen":"2021-07-01"}],"order_statement":"Newest transaction date first, id breaking the tie.","canonical_url":"https://ebomi.com/insider/0001682017","retrieved_at":"2026-08-25T00:02:00+00:00","coverage":{"filings":1506293,"transactions":4290787,"issuers":28597,"insiders":152303,"first_filed_date":"2003-06-30","last_filed_date":"2026-08-21","last_ingest":"2026-08-22T05:23:40.159918+00:00","counts_are":{"filings":"estimate","transactions":"estimate","issuers":"estimate","insiders":"estimate"},"source":"SEC EDGAR Form 4 filings, parsed by ebomi","fault":false},"license":{"underlying_records":"US SEC filings are public records of the United States government and are not subject to copyright. The transactional facts in them are not ours to license.","this_presentation":"The parsing, normalisation, curation, and presentation are ebomi's own work.","grant":"undecided","grant_note":"The open licence for ebomi's own layer is an open owner decision (SPEC-20260731T1159Z open question 3: CC BY 4.0 or CC0 with a citation request). Until it is taken, no grant is asserted here.","citation_request":"Balogh, A. Insider trading. Scientific Data 10, 237 (2023)","url":"https://ebomi.com/license"},"fair_use":{"policy":"These JSON endpoints are open and unauthenticated. Please read them at a human pace, identify your client in the User-Agent header, and use the published dataset for bulk work rather than crawling page by page.","bulk_alternative":"doi:10.1038/s41597-023-02147-6"}}